vaccine

During a recent hearing on vaccine safety, Rep. Marjorie Taylor Greene (R-Ga.) made controversial statements that have drawn criticism from her Democratic colleagues. What Happened: Greene, who is not a medical professional, said, "I'm not a doctor, but I have a Ph.D. in recognizing bulls*...

Key Takeaways: Clover Biopharmaceuticals posted a surge in first-half earnings after a $384 million grant for Covid vaccine development was belatedly folded into its accounts The company has turned its attention to flu vaccines after being hit by waning demand in the crowded Covid market By Molly...

In the midst of a seemingly constant hum of summer activity, something from the past is looming large again: COVID-19. What Happened: New data from the Centers for Disease Control and Prevention (CDC) showed hospitalizations shot up by 12.5% between July 23 and July 29. In fact, they have been...

New York officials have detected polio in the city's wastewater, suggesting the virus has been circulating in the local area. What Happened? On Friday, New York State Health Commissioner Dr. Mary Bassett said city health officials are working to determine how much the polio virus has spread...

A plan to extend the limited supply of monkeypox vaccine in order to provide additional doses has been approved by the Food and Drug Administration. What Happened: CNBC reports that the FDA authorized a new technique of administering Bavarian Nordic A/S’s (OTC: BVNRY) monkeypox...

As COVID-19 continues to mutate and form new variants, the FDA is calling on the major vaccine manufacturers to create a new composition of the vaccine for adults. What Happened: The agency has called on Moderna, Inc. (NASDAQ: MRNA), Pfizer, Inc. (NYSE: PFE), and Novavax, Inc. (NASDAQ: NVAX)...

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Advisors Back Novavax's COVID-19 Vaccine  The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted in favor of Novavax Inc's (...

Novavax, Inc. (NASDAQ: NVAX) announced the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 21 to 0, with one abstention, to recommend that the FDA grant Emergency Use Authorization (EUA) for the Novavax COVID-19 vaccine (NVX-CoV2373...

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Pfizer-BioNTech's COVID-19 Vaccine Booster Shows High Immune Response In Kids Ages 5-11 Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have announced results from a...

Meta Platforms Inc (NASDAQ: FB) recently announced that the company no longer requires employees to have COVID-19 booster shots to enter its offices in the U.S.  "We updated our requirements in early March to align with CDC guidance, and now COVID-19 boosters are no longer required...

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Monday after the company submitted a request to the U.S Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine, NVX-CoV2373. Novavax was up 13% at $93.70 Monday afternoon at publication. See More: Why Novavax...

Key takeaways: Jiangsu Recbio has filed a second IPO application to list in Hong Kong, hoping to become the first HPV vaccine maker in the market The company was valued at around 9 billion yuan after its latest funding round By Molly Wen What started as a chance to participate in trials for an...

There is limited upside from CureVac BV’s (NASDAQ: CVAC) COVID-19 vaccine and there are few catalysts from the rest of the company’s pipeline in 2022, according to BofA Securities. The CureVac Analyst: Geoff Meacham downgraded the rating for CureVac from Neutral to Underperform, while...

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Thursday after Australia’s national drug regulator granted approval for the company's COVID-19 vaccine. The stock is trading below what traders call a pennant pattern and is showing uncertainty in where it could head next....

Apple Inc (NASDAQ: AAPL) has asked its store as well as corporate employees to get a COVID-19 booster shot.  Apple will require unvaccinated employees to provide negative COVID-19 rapid antigen tests before entering the workplace beginning Jan. 24.  Additionally, if an employee is...